Clinical Trials Browser

Unknown × HER2-positive Metastatic Breast Cancer × Clear all

NCT05042791 2024-02-09

A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases

Phase 2 Unknown

HER2-positive Metastatic Breast Cancer

NCT05188495 2022-01-12

HELP

HER2-positive Metastatic Breast Cancer

NCT04385563 2020-05-13

A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.

Phase 3 Unknown

HER2-positive Metastatic Breast Cancer